-
EP2847169
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2847169
| EP2847169 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.01.2018 Database last updated on 27.07.2024 | |
| Former | Examination is in progress Status updated on 04.01.2017 | Most recent event Tooltip | 05.01.2018 | Application deemed to be withdrawn | published on 07.02.2018 [2018/06] | Applicant(s) | For all designated states Cellixbio Private Limited No.1177B, Road No. 56 Jubilee Hills, Hyderabad 500081 / IN | [2015/12] | Inventor(s) | 01 /
KANDULA. Mahesh Door No. 11-61 Samalkot Mandal East Godavari Dist G. Medapadu 533 434 Andhra Pradesh / IN | [2015/12] | Representative(s) | ip21 Ltd Central Formalities Department Suite 2 The Old Dairy Elm Farm Business Park Wymondham Norwich, Norfolk NR18 0SW / GB | [N/P] |
| Former [2015/12] | Jennings, Tara Romaine FRKelly 27 Clyde Road Dublin 4 / IE | Application number, filing date | 13787695.9 | 28.01.2013 | WO2013IB50711 | Priority number, date | IN2012CHE1782 | 07.05.2012 Original published format: IN CH17822012 | [2015/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013167985 | Date: | 14.11.2013 | Language: | EN | [2013/46] | Type: | A1 Application with search report | No.: | EP2847169 | Date: | 18.03.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.11.2013 takes the place of the publication of the European patent application. | [2015/12] | Search report(s) | International search report - published on: | CN | 14.11.2013 | (Supplementary) European search report - dispatched on: | EP | 31.08.2015 | Classification | IPC: | A61K31/55, A61P25/00, A61P25/18, A61P25/28, C07D409/12 | [2015/40] | CPC: |
C07D409/12 (EP,CN,US);
C07D223/28 (EP,CN,US);
A61K31/55 (EP,US);
A61K45/06 (EP,US);
A61K47/543 (US);
A61K47/55 (EP,US);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/08 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/28 (EP);
C07D223/22 (CN)
(-)
|
| Former IPC [2015/12] | C07D223/20, C07D223/22, A61K31/55, A61P25/00, A61P25/18, A61P25/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/12] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG NEUROLOGISCHER ERKRANKUNGEN | [2015/12] | English: | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | [2015/12] | French: | COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE TROUBLES NEUROLOGIQUES | [2015/12] | Entry into regional phase | 08.12.2014 | National basic fee paid | 08.12.2014 | Search fee paid | 08.12.2014 | Designation fee(s) paid | 08.12.2014 | Examination fee paid | Examination procedure | 08.12.2014 | Examination requested [2015/12] | 17.03.2016 | Amendment by applicant (claims and/or description) | 27.07.2016 | Despatch of a communication from the examining division (Time limit: M04) | 03.03.2017 | Reply to a communication from the examining division | 24.04.2017 | Despatch of a communication from the examining division (Time limit: M04) | 05.09.2017 | Application deemed to be withdrawn, date of legal effect [2018/06] | 05.10.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.07.2016 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 03.03.2017 | Request for further processing filed | 03.03.2017 | Full payment received (date of receipt of payment) Request granted | 15.03.2017 | Decision despatched | Fees paid | Renewal fee | 02.02.2015 | Renewal fee patent year 03 | 28.01.2016 | Renewal fee patent year 04 | 25.01.2017 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]FR2173172 (DRESDEN ARZNEIMITTEL [DD]) [X] 1 * examples 1-6 *; | [X]EP1477480 (PORTELA & CA SA [PT]) [X] 1,2 * page 2; compounds (I)-(VI) * * page 1, paragraph 2 *; | [X]WO2007094694 (PORTELA & CA SA [PT], et al) [X] 1-8 * claims 1-25 *; | [X] - BENES J ET AL, "Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide Derivatives", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19990101), vol. 42, doi:10.1021/JM980627G, ISSN 0022-2623, pages 2582 - 2587, XP002206156 [X] 1,2,7,8 * page 2583; compounds 7-8 * * page 2583; table 1; compounds 10-12 * * page 2585; table 5 * * Conclusion, p. 2585 * DOI: http://dx.doi.org/10.1021/jm980627g | [A] - HAASZ FERENC ET AL, "Dibenz(b,f)azepines, part 7: Synthesis of new, potentially CNS active dibenz (b,f)azepine derivatives", ARCHIV DER PHARMAZIE, WILEY VERLAG, WEINHEIM, (19960101), vol. 329, no. 12, doi:10.1002/ARDP.19963291207, ISSN 0365-6233, pages 551 - 553, XP002524412 [A] 1-14 * abstract * * page 552; table 1 * DOI: http://dx.doi.org/10.1002/ardp.19963291207 | [X] - C. DULSAT ET AL, "Eslicarbazepine acetate", DRUGS OF THE FUTURE, (20090101), vol. 34, no. 3, doi:10.1358/dof.2009.034.03.1352675, ISSN 0377-8282, page 189, XP055001396 [X] 1-8 * the whole document * DOI: http://dx.doi.org/10.1358/dof.2009.034.03.1352675 | [A] - TAKAYAMA ET AL, "Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, (20070804), vol. 17, no. 17, doi:10.1016/J.BMCL.2007.06.069, ISSN 0960-894X, pages 4729 - 4732, XP022184898 [A] 1-14 * abstract * * page 4731; table 1; compounds 6-8 * DOI: http://dx.doi.org/10.1016/j.bmcl.2007.06.069 | International search | [A]US4404366 (BOGUSLASKI ROBERT C [US], et al); | [A]EP0141393 (ABBOTT LAB [US]); | [X]WO9413298 (RHONE POULENC RORER SA [FR], et al); | [X]WO2004031155 (NOVARTIS AG [CH], et al) |